MGRM Stock Overview
Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Monogram Technologies Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2.04 |
| 52 Week High | US$6.55 |
| 52 Week Low | US$1.53 |
| Beta | 0 |
| 1 Month Change | -12.45% |
| 3 Month Change | -30.61% |
| 1 Year Change | -57.50% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -82.64% |
Recent News & Updates
Is Monogram Orthopaedics (NASDAQ:MGRM) In A Good Position To Invest In Growth?
Mar 21
Is Monogram Orthopaedics (NASDAQ:MGRM) In A Good Position To Deliver On Growth Plans?
Nov 17Shareholder Returns
| MGRM | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -1.4% | -2.1% | -0.9% |
| 1Y | -57.5% | 4.3% | 25.8% |
Return vs Industry: MGRM underperformed the US Medical Equipment industry which returned 4.3% over the past year.
Return vs Market: MGRM underperformed the US Market which returned 25.8% over the past year.
Price Volatility
| MGRM volatility | |
|---|---|
| MGRM Average Weekly Movement | 28.1% |
| Medical Equipment Industry Average Movement | 8.2% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in US Market | 16.0% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: MGRM's share price has been volatile over the past 3 months.
Volatility Over Time: MGRM's weekly volatility has increased from 18% to 28% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 28 | Ben Sexson | www.monogramorthopedics.com |
Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens.
Monogram Technologies Inc. Fundamentals Summary
| MGRM fundamental statistics | |
|---|---|
| Market cap | US$62.64m |
| Earnings (TTM) | -US$13.39m |
| Revenue (TTM) | US$365.00k |
176.8x
P/S Ratio-4.8x
P/E RatioIs MGRM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MGRM income statement (TTM) | |
|---|---|
| Revenue | US$365.00k |
| Cost of Revenue | US$0 |
| Gross Profit | US$365.00k |
| Other Expenses | US$13.76m |
| Earnings | -US$13.39m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.42 |
| Gross Margin | 100.00% |
| Net Profit Margin | -3,669.65% |
| Debt/Equity Ratio | 0% |
How did MGRM perform over the long term?
See historical performance and comparison